Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Public Health: market research reports

1594

Public health is the science and practice of protecting and improving the health of a community by education, disease and injury prevention, wellness promotion, and health protection. From scientific research to health education, the field of public health strives to improve lives and social conditions that affect the health of a community. It is because of public health that we understand that second-hand smoke can cause cancer, that bicycle helmets can save lives, and that unclean water can carry disease-causing bacteria.

The overall health of a community is affected by social, cultural and economic factors. Health experts explore all aspects of people’s lives in order to fully expose and gauge the multitude of issues that impact community wellness. Public health practitioners are especially qualified as policy advocates and to promote behavioral change and wellness practices. While medical practitioners are interested in the health of individual patients, public health practitioners are interested in the health of the community as a whole. As former Surgeon General C. Everett Koop wrote, "health care is vital to all of us some of the time, but public health is vital to all of us all of the time." Reports in this category will include those aimed at pharmaceutical marketers and diagnostic marketers or those related to health statistics.

RSS Feeds

Public Health market research reports and industry analysis

< prev 1  2  next >
Community Acquired Pneumonia – Pipeline Review, H2 2012
12/26/2012 | published by: Global Markets Direct
... development for Community Acquired Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community Acquired Pneumonia. Community Acquired Pneumonia - ...  |  more...
$2,000.00
Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media
12/11/2012 | published by: IDC
... whether something "small" like an off-the-shelf analytics application or "large" like a full-scale migration of systems and software to a cloud-based delivery model. Usually this is okay. But in the realm of public health, it ...  |  more...
$1,500.00
A comprehensive study of the UK Legionella Control market in 2010, rating & valuing each of the 180 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...  |  more...
$350.00
Community-Acquired Infections – Pipeline Review, H2 2012
7/31/2012 | published by: Global Markets Direct
... for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. 'Community-Acquired Infections - Pipeline Review, H2 2012' ...  |  more...
$500.00
Global Causes of Death to 2020
5/14/2012 | published by: Espicom Healthcare Intelligence
... cause of death by 55 leading and emerging markets Evaluate at global and country level Rank cause of death globally and identify areas of increasing need Access original forecast data not in the public domain  |  more...
$2,265.00
Community-Acquired Infections - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. 'Community-Acquired Infections - Pipeline Review, H1 2012' ...  |  more...
$500.00
Epidemiology: Hepatitis C in China – Epidemic yet to reach its peak
11/15/2011 | published by: Datamonitor
... more than 40 million people are estimated to be infected with HCV, thereby presenting a huge single market potential for anti-HCV drugs. Features and benefits Gain insights into the estimates and forecast of prevalent HCV ...  |  more...
$7,600.00
Comparative Guide to Health in America
7/1/2011 | published by: Grey House Publishing Inc
... infant mortality to air quality, children in poverty to access to healthcare. This important new reference will offer a comprehensive look at the health of America, from the county level, with detailed profiles, ratings and ...  |  more...
$150.00
The 2011-2016 World Outlook for Government Public Health Activities
1/20/2011 | published by: Icon Group International, Inc.
... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ...  |  more...
$795.00
H1N1 (Swine Influenza) - Pipeline Review, Q4 2010
12/29/2010 | published by: Global Markets Direct
... on the therapeutic development for H1N1 (Swine Influenza) Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 (Swine Influenza) ...  |  more...
$500.00
Pricing and Reimbursement of Antivirals
6/1/2010 | published by: Decision Resources
... treatments for both chronic and acute viral infections. Faced with growing expenditures on these medicines, governments and other payers are struggling to strike a balance between maintaining public health and preserving their finances. Based on ...  |  more...
$4,600.00
H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
5/1/2010 | published by: Kalorama Information
... manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play ...  |  more...
$1,200.00
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
10/13/2009 | published by: Decision Resources
... be warranted, given that no infectious disease has killed more people in a short period of time than influenza. Without preventive measures-such as vaccines-the current A/H1N1 ("swine flu") 2009 pandemic could claim more than 1 ...  |  more...
$9,200.00
Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
8/6/2009 | published by: Datamonitor
... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Scope Strategic analysis of the current influenza market across the US, Japan, France, Germany, Italy, ...  |  more...
$15,200.00
Seasonal Influenza Vaccines Market Forecast
8/6/2009 | published by: Datamonitor
... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Reasons to Purchase Review the clinical and commercial factors driving new product decisions in influenza ...  |  more...
$15,200.00
The Global Influenza Market
8/1/2009 | published by: BCC Research
... the segments of vaccines/therapeutics and diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis Covers some of the most significant issues, trends and market factors ...  |  more...
$4,850.00
Eclipsys: An HIT First Responder with H1N1 Influenza Toolkit
5/18/2009 | published by: IDC
... United States, Eclipsys released an influenza A H1N1 (swine flu) outcomes toolkit that is designed to help hospitals using its electronic medical record (EMR) to limit the spread of influenza in hospital waiting areas. It ...  |  more...
$1,500.00
MarketVIEW: H1N1 vaccine (US demand model)
5/1/2009 | published by: VacZine Analytics
... infection with over half of the cases being identified in the continental United States. Using currently available information regarding the expected profile, possible allocation of H1N1 specific vaccine and predictions of pandemic severity, VacZine Analytics ...  |  more...
$1,995.00
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
5/1/2009 | published by: Kalorama Information
... appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both ...  |  more...
$250.00
The 2009 Report on Government Public Health Activities: World Market Segmentation by City
5/1/2009 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...  |  more...
$795.00
Research Report Chinese Bird Flu Vaccine Industry, 2009
4/28/2009 | published by: China Research and Intelligence Co., Ltd.
... may be more difficult to deal with those newly-discovered diseases which often result in big disaster for people know little about it. Zoonosis is usually caused by such close contacts between animals and human beings ...  |  more...
$1,599.00
MarketVIEW: pre-pandemic vaccines
3/1/2009 | published by: VacZine Analytics
... has caused high mortality in poultry and occasionally infects humans in close contact with around 60% of cases (408) so far being fatal. As of February 27th 2009 confirmed H5N1 Avian influenza deaths in humans ...  |  more...
$8,995.00
Diseaseinfopack: Pre-pandemic Vaccines
3/1/2009 | published by: VacZine Analytics
... H5N1 Avian influenza deaths in humans have reached 256, a significant increase upon 2004 when measurements began. This expert report provides a comprehensive up-to-date critical review of current global pandemic preparedness and planning with regard ...  |  more...
$6,995.00
Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In times of crisis, Big Pharma turns to vaccines
12/18/2008 | published by: Datamonitor
... Co's Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies. Scope Market overview with current market assessment in terms ...  |  more...
$15,200.00
Binge Drinking & Moderation in Alcoholic Drinks
11/10/2008 | published by: Datamonitor
... report examines consumer attitudes towards alcohol, cultural drinking trends and the importance of promoting responsible drinking at a time when alcohol misuse is attracting widespread negative attention. Scope Detailed insights and analysis documenting alcoholic beverage ...  |  more...
$3,995.00
< prev 1  2  next >